Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor
- PMID: 9173898
- PMCID: PMC1218311
- DOI: 10.1042/bj3230033
Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: competition between prothrombin and inhibitor
Abstract
The inhibition of prothrombinase by tissue factor pathway inhibitor (TFPI) has been studied in the presence and absence of prothrombin. The rate constant of association of prothrombinase with full-length TFPI was 2.1x10(7) M-1.s-1 and 0.05x10(7) M-1.s-1 for the reaction with C-terminus truncated TFPI (TFPI1-161). The rate constant of dissociation was 0.65x10(-4) s-1 in both cases. The rate constant of inhibition of prothrombinase by TFPI1-161 was similar to that of solution-phase factor Xa. In contrast, phospholipids and factor Va enhanced the association rate of the reaction between factor Xa and full-length TFPI by approx. 20-fold. Although TFPI, and in particular the full-length variant of the molecule, is a potent inhibitor of prothrombinase (overall inhibition constant of 3 pM), we also found that prothrombin competed very effectively with TFPI for the active site of factor Xa in the prothrombinase complex. A 50% reduction of the rate constant of inhibition was measured in the presence of 4 nM prothrombin, i.e. 0.2% of the plasma concentration of prothrombin. The physiological significance of TFPI as an inhibitor of prothrombinase activity is thus questionable.
Similar articles
-
Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase.Blood. 1996 Mar 1;87(5):1845-50. Blood. 1996. PMID: 8634431
-
Contribution of regions distal to glycine-160 to the anticoagulant activity of tissue factor pathway inhibitor.Biochemistry. 2002 Apr 16;41(15):4989-97. doi: 10.1021/bi016058n. Biochemistry. 2002. PMID: 11939795
-
Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo.Br J Haematol. 1996 Dec;95(4):738-46. doi: 10.1046/j.1365-2141.1996.d01-1963.x. Br J Haematol. 1996. PMID: 8982054
-
Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfaces.Haemostasis. 1996 Oct;26 Suppl 4:89-97. doi: 10.1159/000217289. Haemostasis. 1996. PMID: 8979115 Review.
-
Protein S is a cofactor for tissue factor pathway inhibitor.Thromb Res. 2008;122 Suppl 1:S60-3. doi: 10.1016/S0049-3848(08)70021-5. Thromb Res. 2008. PMID: 18691502 Review.
Cited by
-
Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.Blood. 2005 May 15;105(10):3902-9. doi: 10.1182/blood-2004-11-4435. Epub 2005 Jan 27. Blood. 2005. PMID: 15677561 Free PMC article.
-
Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.Proc Natl Acad Sci U S A. 2013 Oct 29;110(44):17838-43. doi: 10.1073/pnas.1310444110. Epub 2013 Oct 14. Proc Natl Acad Sci U S A. 2013. PMID: 24127605 Free PMC article.
-
Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State.Blood Adv. 2017 Feb 14;1(6):386-395. doi: 10.1182/bloodadvances.2016002295. Blood Adv. 2017. PMID: 28580443 Free PMC article.
-
Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.Br J Haematol. 2016 Oct;175(1):123-32. doi: 10.1111/bjh.14182. Epub 2016 Jun 15. Br J Haematol. 2016. PMID: 27301751 Free PMC article.
-
TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation.Blood Adv. 2017 Dec 26;1(27):2692-2702. doi: 10.1182/bloodadvances.2017011098. Blood Adv. 2017. PMID: 29291252 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous